Investment trust

International Biotechnology Ord

ISIN
GB0004559349

How good is this fund, really?

See the rating in the app

About International Biotechnology Ord

International Biotechnology Ord pays a yearly dividend equal to 4% of its net asset value at the end of the prior financial year, in two equal parts in January and August. The closed-end investment trust, managed by Schroder Unit Trusts Limited, targets long-term capital growth from biotechnology and other life sciences companies, plus medical devices and healthcare services. Most of the money is in quoted biotech shares of all sizes, mainly in North America, with room for Europe, Asia, Australia, unquoted companies and venture capital funds. One company is normally capped at 15% of gross assets on purchase, and gearing at 30% of net assets. The yardstick to beat is the NASDAQ Biotechnology Index (NBI) in sterling. Ongoing charges were 1.30% in the year to 31 August 2025. Risk class 5 of 7; minimum suggested holding five years.

Watch this fund for free Add International Biotechnology Ord to your watchlist in the PowerFunds app and we tell you when it falls behind the rest of its category.

Watch the fund for free

Where to buy International Biotechnology Ord — platforms and fees

Sold on 4 platforms we follow.

International Biotechnology Ord — its category

Sector Equity Biotechnology — PowerFunds rates 55 funds in this category every month.

Biotechnology funds →

Other funds